Evidence map›Paper›PMID 31374245›Full record

ArticleNeurobiology of disease2020

Preface: Discovery and development of better medical countermeasures for chemical threats targeting the nervous system.

David A Jett, Aristea S Galanopoulou, Solomon L Moshé

Abstract readEditorial
In one paragraph

Article in Neurobiology of disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David A JettNational Institute of Neurological Disorders and Stroke, National Institutes of Health, USA. Electronic address: jettd@ninds.nih.gov.
Aristea S GalanopoulouIsabelle Rapin Division of Child Neurology, Saul R. Korey Department of Neurology, Dominick P. Purpura Department of Neuroscience, Laboratory of Developmental Epilepsy, Comprehensive Einstein/Montefiore Epilepsy, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: aristea.galanopoulou@einstein.yu.edu.
Solomon L MoshéIsabelle Rapin Division of Child Neurology, Saul R. Korey Department of Neurology, Dominick P. Purpura Department of Neuroscience, Laboratory of Developmental Epilepsy, Comprehensive Einstein/Montefiore Epilepsy, Albert Einstein College of Medicine, Bronx, NY, USA; Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: solomon.moshe@einstein.yu.edu.

Funding

The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) Public Engagement CoreU54NS100064 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ENGEL, JEROME NONE, GALANOPOULOU, ARISTEA S · 2017 to 2021
$21.7M
Consequences of Prolonged Febrile Seizures in ChildhoodR01NS043209 · NINDS · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI SHINNAR, SHLOMO · 2003 to 2012
$21.5M
Consequences of Prolonged Febrile Seizures in ChildhoodR37NS043209 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI SHINNAR, SHLOMO · 2013 to 2019
$11.4M
GABA-inflammation interplay in infantile spasmsR01NS091170 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI GALANOPOULOU, ARISTEA S · 2015 to 2020
$1.9M
NINDS NIH HHS R01 NS043209NINDS NIH HHS R01 NS091170NINDS NIH HHS R37 NS043209NINDS NIH HHS U54 NS100064
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Medical CountermeasuresNeurotoxicity SyndromesAnimalsAntidotesHumansNerve AgentsAntidotesNerve Agents

Identifiers

PMID31374245
PMCPMC6904429

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.